Gregory Rullo

AstraZeneca
Executive Director, Regulatory Affairs-CMC
Greg Rullo is an Executive Director and Innovation Lead in CMC Regulatory Affairs at AstraZeneca and has a wide range of experience in the strategic and tactical aspects of pharmaceutical drug development and global regulatory cmc knowledge. This regulatory knowledge/experience includes CMC specific knowledge of requirements of global cmc requirements with a detailed understanding of submission requirements in all major markets. He has direct experience with Health Authorities meetings throughout the world including: FDA, EMA, ANVISA, Health Canada and Chinese authorities. He was AstraZeneca’s Global Program Director for the integration and implementation of AstraZeneca’s sole regulatory document management, regulatory publishing and submission tracking systems. Current focus is on digitalization of CMC information in Module 3 driving a data centric approach.

Related Articles

Global Collaborative Review: Understanding Overall Control Strategy and Patient Benefit-Risk
Features
Global Collaborative Review: Understanding Overall Control Strategy and Patient Benefit-Risk

The pharmaceutical industry faces considerable challenges throughout the development, manufacturing, and supply of medicines, largely due to the intricate and divergent global regulatory landscape. The adoption of structured data standards and utilization of cloud-based platforms offer immense potential to overcome these challenges by facilitating faster and more efficient global...

Figure 3: Industry develops a single global control strategy.
Features
Toward a Single Global Control Strategy: Industry Study

During the past decade, industry has experienced a proliferation of regulatory divergence regarding the interpretation and implementation of International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines (and control strategies) across geographic regions. This article shares data that highlight instances where well-established ICH...